PMID- 27218255 OWN - NLM STAT- MEDLINE DCOM- 20170718 LR - 20190213 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 11 IP - 5 DP - 2016 TI - Mapping Breakpoints of Complex Chromosome Rearrangements Involving a Partial Trisomy 15q23.1-q26.2 Revealed by Next Generation Sequencing and Conventional Techniques. PG - e0154574 LID - 10.1371/journal.pone.0154574 [doi] LID - e0154574 AB - Complex chromosome rearrangements (CCRs), which are rather rare in the whole population, may be associated with aberrant phenotypes. Next-generation sequencing (NGS) and conventional techniques, could be used to reveal specific CCRs for better genetic counseling. We report the CCRs of a girl and her mother, which were identified using a combination of NGS and conventional techniques including G-banding, fluorescence in situ hybridization (FISH) and PCR. The girl demonstrated CCRs involving chromosomes 3 and 8, while the CCRs of her mother involved chromosomes 3, 5, 8, 11 and 15. HumanCytoSNP-12 Chip analysis identified a 35.4 Mb duplication on chromosome 15q21.3-q26.2 in the proband and a 1.6 Mb microdeletion at chromosome 15q21.3 in her mother. The proband inherited the rearranged chromosomes 3 and 8 from her mother, and the duplicated region on chromosome 15 of the proband was inherited from the mother. Approximately one hundred genes were identified in the 15q21.3-q26.2 duplicated region of the proband. In particular, TPM1, SMAD6, SMAD3, and HCN4 may be associated with her heart defects, and HEXA, KIF7, and IDH2 are responsible for her developmental and mental retardation. In addition, we suggest that a microdeletion on the 15q21.3 region of the mother, which involved TCF2, TCF12, ADMA10 and AQP9, might be associated with mental retardation. We delineate the precise structures of the derivative chromosomes, chromosome duplication origin and possible molecular mechanisms for aberrant phenotypes by combining NGS data with conventional techniques. FAU - Pan, Qiong AU - Pan Q AD - Laboratory of Clinical Genetics, Huai'an Maternity and Child Health Care Hospital of Jiangsu Province, Yangzhou University, Huai'an, China. FAU - Hu, Hao AU - Hu H AD - Department of Medical Genetics, Hunan Provincial Maternal and Child Health Hospital, Changsha, China. FAU - Han, Liangrong AU - Han L AD - Department of Pediatrics, Huai'an Maternity and Child Health Care Hospital of Jiangsu Province, Huai'an, China. FAU - Jing, Xin AU - Jing X AD - Laboratory of Clinical Genetics, Huai'an Maternity and Child Health Care Hospital of Jiangsu Province, Yangzhou University, Huai'an, China. FAU - Liu, Hailiang AU - Liu H AD - CapitalBio Genomics Co., Ltd, Dongguan, China. FAU - Yang, Chuanchun AU - Yang C AD - BGI-Shenzhen, Shenzhen, China. FAU - Zhang, Fengting AU - Zhang F AD - Laboratory of Clinical Genetics, Huai'an Maternity and Child Health Care Hospital of Jiangsu Province, Yangzhou University, Huai'an, China. FAU - Hu, Yue AU - Hu Y AD - Laboratory of Clinical Genetics, Huai'an Maternity and Child Health Care Hospital of Jiangsu Province, Yangzhou University, Huai'an, China. FAU - Yue, Hongni AU - Yue H AD - Department of Pediatrics, Huai'an Maternity and Child Health Care Hospital of Jiangsu Province, Huai'an, China. FAU - Ning, Ying AU - Ning Y AD - Laboratory of Clinical Genetics, Huai'an Maternity and Child Health Care Hospital of Jiangsu Province, Yangzhou University, Huai'an, China. LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160524 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Adult MH - Chromosome Aberrations MH - Chromosome Banding MH - Chromosomes, Human, Pair 15/*genetics MH - Female MH - Genetic Predisposition to Disease MH - High-Throughput Nucleotide Sequencing/*methods MH - Humans MH - In Situ Hybridization, Fluorescence MH - Infant, Newborn MH - Intellectual Disability/*genetics MH - Oligonucleotide Array Sequence Analysis MH - Polymorphism, Single Nucleotide MH - Sequence Analysis, DNA/*methods MH - *Trisomy PMC - PMC4878739 COIS- Competing Interests: The authors have the following interests: Hailiang Liu is employed by CapitalBio Genomics Co., Ltd. Chuanchun Yang is employed by BGI-Shenzhen. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. EDAT- 2016/05/25 06:00 MHDA- 2017/07/19 06:00 PMCR- 2016/05/24 CRDT- 2016/05/25 06:00 PHST- 2015/01/14 00:00 [received] PHST- 2016/04/16 00:00 [accepted] PHST- 2016/05/25 06:00 [entrez] PHST- 2016/05/25 06:00 [pubmed] PHST- 2017/07/19 06:00 [medline] PHST- 2016/05/24 00:00 [pmc-release] AID - PONE-D-15-00933 [pii] AID - 10.1371/journal.pone.0154574 [doi] PST - epublish SO - PLoS One. 2016 May 24;11(5):e0154574. doi: 10.1371/journal.pone.0154574. eCollection 2016.